BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24419232)

  • 1. Paradoxic effects of metformin on endothelial cells and angiogenesis.
    Dallaglio K; Bruno A; Cantelmo AR; Esposito AI; Ruggiero L; Orecchioni S; Calleri A; Bertolini F; Pfeffer U; Noonan DM; Albini A
    Carcinogenesis; 2014 May; 35(5):1055-66. PubMed ID: 24419232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
    Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL
    Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
    Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis.
    Webler AC; Michaelis UR; Popp R; Barbosa-Sicard E; Murugan A; Falck JR; Fisslthaler B; Fleming I
    Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1292-301. PubMed ID: 18787075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner.
    Fraineau S; Monvoisin A; Clarhaut J; Talbot J; Simonneau C; Kanthou C; Kanse SM; Philippe M; Benzakour O
    Blood; 2012 Dec; 120(25):5073-83. PubMed ID: 23065156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial-protective effects of metformin under high glucose in HUVECs.
    Xu J; Liu M; Yu M; Shen J; Zhou J; Hu J; Zhou Y; Zhang W
    IUBMB Life; 2019 Sep; 71(9):1391-1400. PubMed ID: 31120617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMP kinase activation improves angiogenesis in pulmonary artery endothelial cells with in utero pulmonary hypertension.
    Teng RJ; Du J; Afolayan AJ; Eis A; Shi Y; Konduri GG
    Am J Physiol Lung Cell Mol Physiol; 2013 Jan; 304(1):L29-42. PubMed ID: 23103561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
    Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
    Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.
    Pang X; Yi T; Yi Z; Cho SG; Qu W; Pinkaew D; Fujise K; Liu M
    Cancer Res; 2009 Jan; 69(2):518-25. PubMed ID: 19147565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-C Motif Chemokine 8 promotes angiogenesis in vascular endothelial cells.
    Xue S; Tang H; Zhao G; Shen Y; Yang EY; Fu W; Shi Z; Tang X; Guo D
    Vascular; 2021 Jun; 29(3):429-441. PubMed ID: 32972333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis.
    Kroll J; Epting D; Kern K; Dietz CT; Feng Y; Hammes HP; Wieland T; Augustin HG
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H893-9. PubMed ID: 19181962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
    Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK.
    Ying Y; Ueta T; Jiang S; Lin H; Wang Y; Vavvas D; Wen R; Chen YG; Luo Z
    Oncotarget; 2017 May; 8(20):32794-32806. PubMed ID: 28427181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.
    Bakhashab S; Ahmed FW; Schulten HJ; Bashir A; Karim S; Al-Malki AL; Gari MA; Abuzenadah AM; Chaudhary AG; Alqahtani MH; Lary S; Ahmed F; Weaver JU
    Cardiovasc Diabetol; 2016 Feb; 15():27. PubMed ID: 26861446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase.
    Chiu WC; Chiou TJ; Chung MJ; Chiang AN
    PLoS One; 2016; 11(8):e0161950. PubMed ID: 27579889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.